Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101] (ESMO Open (2021) 6(3), (S2059702921000582), (10.1016/j.esmoop.2021.100101))

T. K. Choueiri; J. Larkin; S. Pal; R. J. Motzer; B. I. Rini; B. Venugopal; B. Alekseev; H. Miyake; G. Gravis; M. A. Bilen; S. Hariharan; A. Chudnovsky; K. A. Ching; X. J. Mu; M. Mariani; P. B. Robbins; B. Huang; A. di Pietro; L. Albiges

doi:10.1016/j.esmoop.2021.100177

Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101] (ESMO Open (2021) 6(3), (S2059702921000582), (10.1016/j.esmoop.2021.100101))

T. K. Choueiri, J. Larkin, S. Pal, R. J. Motzer, B. I. Rini, B. Venugopal, B. Alekseev, H. Miyake, G. Gravis, M. A. Bilen, S. Hariharan, A. Chudnovsky, K. A. Ching, X. J. Mu, M. Mariani, P. B. Robbins, B. Huang, A. di Pietro, L. Albiges

Résultats de recherche: Contribution à un journal › !!Comment/debate

Résumé

The publisher regrets that some minor corrections to punctuation were missed in the typesetting process. In addition, Figure 3C was incorrect when the article was published. All corrections have now been applied to the article and the figure corrected. The corrected Figure 3C also appears below: [Figure presented] The publisher would like to apologise for any inconvenience caused.

langue originale	Anglais
Numéro d'article	100177
journal	ESMO Open
Volume	6
Numéro de publication	4
Les DOIs	https://doi.org/10.1016/j.esmoop.2021.100177
état	Publié - 1 août 2021

Accès au document

10.1016/j.esmoop.2021.100177

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Choueiri, T. K., Larkin, J., Pal, S., Motzer, R. J., Rini, B. I., Venugopal, B., Alekseev, B., Miyake, H., Gravis, G., Bilen, M. A., Hariharan, S., Chudnovsky, A., Ching, K. A., Mu, X. J., Mariani, M., Robbins, P. B., Huang, B., di Pietro, A., & Albiges, L. (2021). Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101] (ESMO Open (2021) 6(3), (S2059702921000582), (10.1016/j.esmoop.2021.100101)). ESMO Open, 6(4), Article 100177. https://doi.org/10.1016/j.esmoop.2021.100177

Choueiri, T. K. ; Larkin, J. ; Pal, S. et al. / Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma : post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101] (ESMO Open (2021) 6(3), (S2059702921000582), (10.1016/j.esmoop.2021.100101)). Dans: ESMO Open. 2021 ; Vol 6, Numéro 4.

@article{c8bd09083bc542ee99bbe7a76c7eebf7,

title = "Erratum to {\textquoteleft}Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial{\textquoteright}: [ESMO Open Volume 6, Issue 3, June 2021, 100101] (ESMO Open (2021) 6(3), (S2059702921000582), (10.1016/j.esmoop.2021.100101))",

abstract = "The publisher regrets that some minor corrections to punctuation were missed in the typesetting process. In addition, Figure 3C was incorrect when the article was published. All corrections have now been applied to the article and the figure corrected. The corrected Figure 3C also appears below: [Figure presented] The publisher would like to apologise for any inconvenience caused.",

author = "Choueiri, {T. K.} and J. Larkin and S. Pal and Motzer, {R. J.} and Rini, {B. I.} and B. Venugopal and B. Alekseev and H. Miyake and G. Gravis and Bilen, {M. A.} and S. Hariharan and A. Chudnovsky and Ching, {K. A.} and Mu, {X. J.} and M. Mariani and Robbins, {P. B.} and B. Huang and {di Pietro}, A. and L. Albiges",

note = "Publisher Copyright: {\textcopyright} 2021 The Author(s)",

year = "2021",

month = aug,

day = "1",

doi = "10.1016/j.esmoop.2021.100177",

language = "English",

volume = "6",

journal = "ESMO Open",

issn = "2059-7029",

number = "4",

}

Choueiri, TK, Larkin, J, Pal, S, Motzer, RJ, Rini, BI, Venugopal, B, Alekseev, B, Miyake, H, Gravis, G, Bilen, MA, Hariharan, S, Chudnovsky, A, Ching, KA, Mu, XJ, Mariani, M, Robbins, PB, Huang, B, di Pietro, A & Albiges, L 2021, 'Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101] (ESMO Open (2021) 6(3), (S2059702921000582), (10.1016/j.esmoop.2021.100101))', ESMO Open, VOL. 6, Numéro 4, 100177. https://doi.org/10.1016/j.esmoop.2021.100177

Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101] (ESMO Open (2021) 6(3), (S2059702921000582), (10.1016/j.esmoop.2021.100101)). / Choueiri, T. K.; Larkin, J.; Pal, S. et al.
Dans: ESMO Open, Vol 6, Numéro 4, 100177, 01.08.2021.

Résultats de recherche: Contribution à un journal › !!Comment/debate

TY - JOUR

T1 - Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma

T2 - post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101] (ESMO Open (2021) 6(3), (S2059702921000582), (10.1016/j.esmoop.2021.100101))

AU - Choueiri, T. K.

AU - Larkin, J.

AU - Pal, S.

AU - Motzer, R. J.

AU - Rini, B. I.

AU - Venugopal, B.

AU - Alekseev, B.

AU - Miyake, H.

AU - Gravis, G.

AU - Bilen, M. A.

AU - Hariharan, S.

AU - Chudnovsky, A.

AU - Ching, K. A.

AU - Mu, X. J.

AU - Mariani, M.

AU - Robbins, P. B.

AU - Huang, B.

AU - di Pietro, A.

AU - Albiges, L.

PY - 2021/8/1

Y1 - 2021/8/1

N2 - The publisher regrets that some minor corrections to punctuation were missed in the typesetting process. In addition, Figure 3C was incorrect when the article was published. All corrections have now been applied to the article and the figure corrected. The corrected Figure 3C also appears below: [Figure presented] The publisher would like to apologise for any inconvenience caused.

AB - The publisher regrets that some minor corrections to punctuation were missed in the typesetting process. In addition, Figure 3C was incorrect when the article was published. All corrections have now been applied to the article and the figure corrected. The corrected Figure 3C also appears below: [Figure presented] The publisher would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85115451676&partnerID=8YFLogxK

U2 - 10.1016/j.esmoop.2021.100177

DO - 10.1016/j.esmoop.2021.100177

M3 - Comment/debate

C2 - 34474809

AN - SCOPUS:85115451676

SN - 2059-7029

VL - 6

JO - ESMO Open

JF - ESMO Open

IS - 4

M1 - 100177

ER -

Choueiri TK, Larkin J, Pal S, Motzer RJ, Rini BI, Venugopal B et al. Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101] (ESMO Open (2021) 6(3), (S2059702921000582), (10.1016/j.esmoop.2021.100101)). ESMO Open. 2021 août 1;6(4):100177. doi: 10.1016/j.esmoop.2021.100177